<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M668</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M668</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>2-{5-(1,3-Benzodioxol-5-yl)-1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-4,5-dihydro-1<italic>H</italic>-pyrazol-3-yl}pyrazine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jothikrishnan</surname>
            <given-names>Balapragalathan Thappali</given-names>
          </name>
          <xref rid="c1-molbank-2010-M668" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narasimhan</surname>
            <given-names>Sriram</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shafi</surname>
            <given-names>Suban Syed</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M668">Department of Chemistry, Islamiah  College, Vaniyambadi- 635 751, Tamilnadu, India</aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M668"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>bala.pragalathan@gmail.com</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>03</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>03</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>1</issue>
      <elocation-id>M668</elocation-id>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>03</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>03</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A simple method for the synthesis of a pyrazolyl thiazole derivative containing a piperonal moiety was developed. Thus, 2-{5-(1,3-benzodioxol-5-yl)-1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-4,5-dihydro-1<italic>H</italic>-pyrazol-3-yl}pyrazine was synthesized using microwave irradiation and characterized by NMR, IR and LCMS data.</p>
      </abstract>
      <kwd-group>
        <kwd>5-(1,3-benzodioxol-5-yl)-3-(pyrazin-2-yl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carbothioamide</kwd>
        <kwd>4-chlorophenacyl bromide</kwd>
        <kwd>microwave</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Heterocyclic molecules can act as highly functionalized scaffolds and are known pharmacophores of a number of biologically active and medicinally useful molecules [<xref ref-type="bibr" rid="B1-molbank-2010-M668">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2010-M668">2</xref>].</p>
      <p>Electron-rich nitrogen heterocyclics play an important role in diverse biological activities. Introducing a pyrazolidinone [<xref ref-type="bibr" rid="B3-molbank-2010-M668">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2010-M668">4</xref>] ring in place of a &#x3B2;-lactam ring in penicillins and cephalosporins [<xref ref-type="bibr" rid="B5-molbank-2010-M668">5</xref>] results in enhanced activity. A second nitrogen in the five-membered ring also influences the antibacterial or pharmacokinetic properties [<xref ref-type="bibr" rid="B6-molbank-2010-M668">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2010-M668">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2010-M668">8</xref>]. 2-Pyrazoline derivatives have also been reported in the literature to exhibit various pharmacological activities such as antimicrobial [<xref ref-type="bibr" rid="B9-molbank-2010-M668">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2010-M668">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2010-M668">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2010-M668">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2010-M668">13</xref>,<xref ref-type="bibr" rid="B14-molbank-2010-M668">14</xref>], anti-inflammatory [<xref ref-type="bibr" rid="B15-molbank-2010-M668">15</xref>] and antihypertensive [<xref ref-type="bibr" rid="B16-molbank-2010-M668">16</xref>].</p>
      <p>On the other hand, sulfur and/or nitrogen heterocycles that possess pharmacological activities widely occur in nature in the form of alkaloids, vitamins, pigments and as constituents of plant and animal cells. Penicillins containing a thiazole ring system (thiazolidine) [<xref ref-type="bibr" rid="B17-molbank-2010-M668">17</xref>] are also important naturally occurring products. Thiazoles and their derivatives are found to be associated with various biological activities such as antimicrobial [<xref ref-type="bibr" rid="B18-molbank-2010-M668">18</xref>,<xref ref-type="bibr" rid="B19-molbank-2010-M668">19</xref>,<xref ref-type="bibr" rid="B20-molbank-2010-M668">20</xref>,<xref ref-type="bibr" rid="B21-molbank-2010-M668">21</xref>,<xref ref-type="bibr" rid="B22-molbank-2010-M668">22</xref>,<xref ref-type="bibr" rid="B23-molbank-2010-M668">23</xref>,<xref ref-type="bibr" rid="B24-molbank-2010-M668">24</xref>], antituberculosis [<xref ref-type="bibr" rid="B25-molbank-2010-M668">25</xref>], and anti-HIV [<xref ref-type="bibr" rid="B26-molbank-2010-M668">26</xref>] activities.</p>
      <p>In the interest of the above suggestion, we planned to synthesize a system that combines together two biolabile components which are 2-pyrazoline and thiazole. We are hereby reporting a simple method for synthesizing a pyrazolyl thiazole derivative, using a microwave condition, which does not need any catalyst. The work-up procedure is simple and convenient.</p>
	  <fig id="molbank-2010-M668-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2010-M668-sch001_Scheme</object-id>
        <label>Scheme</label>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M668-sch001.tif"/>
      </fig>
	  </sec>
	  <sec>
      <title>Experimental</title>
      <p>A solution of (<bold>1</bold>) (0.327 g, 1 mmol) which was prepared by the reaction between corresponding chalcone and thiosemicarbazide and (<bold>2</bold>) (0.223 g,1 mmol) in absolute ethanol (5 mL) was placed in a microwave Pyrex vial and irradiated with 200W for 10 min at 150 &#xB0;C (final temperature). The reaction mixture was cooled to room temperature and concentrated. The solid obtained was washed with a little amount of hexane, filtered and dried under vacuum to give a yellow-coloured solid (<bold>3</bold>).</p>
      <p>Yield = 80%</p>
      <p>M.p. = 186.6 &#xB0;C</p>
      <p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x3B4; = 9.38 (s, 1H), 8.52&#x2013;8.50 (m, 2H), 7.64&#x2013;7.61 (m, 2H), 7.31&#x2013;7.28 (m, 2H), 6.90 (q, 1H), 6.84 (s, 2H), 6.79&#x2013;6.77 (d, <italic>J</italic> = 8 Hz, 1H), 5.92 (s, 2H), 5.68 (q, 1H), 3.97 (dd, <italic>J</italic> = 12 Hz, 18 Hz, 1H), 3.49 (dd, <italic>J</italic> = 4 Hz, 16 Hz, 1H).</p>
      <p><sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): 164.17, 150.73, 150.49, 148.08, 147.31, 146.66, 143.80, 143.76, 143.23, 135.03, 133.30, 133.19, 128.62, 127.16, 120.36, 108.27, 106.81, 104.43, 101.16, 64.79 and 42.68.</p>
      <p>MS: m/z (ES), 462 [(M+1)<sup>+</sup>].</p>
      <p>IR: cm<sup>&#x2212;1</sup> = 3849, 3624, 3115, 2921, 2301, 1574, 1538, 1512, 1501, 1487, 1469, 1431, 1401, 1371, 1318,1 288, 1270, 1241, 1192, 1166, 1148, 1135, 1116, 1085, 1073, 1038, 1009, 970, 938, 896, 844, 824, 757, 732, 681, 630, 404.</p>
      <p>Elemental analysis: calculated for C<sub>23</sub>H<sub>16</sub>ClN<sub>5</sub>O<sub>2</sub>S &#xB7; 0.25 H<sub>2</sub>O (466.44): C, 59.23%; H, 3.57%; N, 15.01%; S, 6.87%. Found: C, 59.35%; H, 3.59%; N, 14.52%; S, 7.02%.</p>
    </sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2010-M668">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M668-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M668-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M668-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M668-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
	<ack>
      <title>Acknowledgements</title>
      <p>The authors thank Syngene Intl. Ltd. Bangalore, India for providing the analytical facilities to carry out the research work and also thank Islamiah College for providing all other facilities.</p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2010-M668">
        <label>1.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Silverman</surname>
              <given-names>R.B.</given-names>
            </name>
          </person-group>
          <source>Organic Chemistry of Drug Design and Drug Action</source>
          <publisher-name>Academic Press</publisher-name>
          <publisher-loc>San Diego, CA, USA</publisher-loc>
          <year>1992</year>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M668">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Ellman</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Applications of small molecule libraries</article-title>
          <source>Chem. Rev.</source>
          <year>1996</year>
          <volume>96</volume>
          <fpage>555</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="doi">10.1021/cr9402081</pub-id>
          <pub-id pub-id-type="pmid">11848765</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M668">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jungheim</surname>
              <given-names>L.N.</given-names>
            </name>
            <name>
              <surname>Sigmund</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Bicyclic pyrazolidinones, a new class of antibacterial agent based on the &#x3B2;-lactam model</article-title>
          <source>Tetrahedron Lett.</source>
          <year>1987</year>
          <volume>28</volume>
          <fpage>285</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4039(00)95708-3</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M668">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jungheim</surname>
              <given-names>L.N.</given-names>
            </name>
            <name>
              <surname>Sigmund</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Swartzendruber</surname>
              <given-names>J.K.</given-names>
            </name>
          </person-group>
          <article-title>Bicyclic pyrazolidinones, steric electronic effects on antibacterial activity</article-title>
          <source>Tetrahedron Lett.</source>
          <year>1987</year>
          <volume>28</volume>
          <fpage>289</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4039(00)95709-5</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M668">
        <label>5.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Boyd</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Morin</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Gorman</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Theoretical and Physicochemical studies on &#x3B2;-Lactam Antibiotics in &#x3B2;-Lactam Antibiotics, Chemistry and Biology</source>
          <publisher-name>Academic press</publisher-name>
          <publisher-loc>New York, NY, USA</publisher-loc>
          <year>1982</year>
          <volume>Volume 1</volume>
          <fpage>437</fpage>
          <lpage>545</lpage>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M668">
        <label>6.</label>
        <citation citation-type="confproc">
          <person-group person-group-type="author">
            <name>
              <surname>Jungheim</surname>
              <given-names>L.N.</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Ott</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Ternansky</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Draheim</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Neel</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Stepherd</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Sigmund</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <source>Abstracts of 26th Interscience Conference on Antimicrobial Agents and Chemotherapy</source>
          <conf-loc>New Orleans, LA, USA</conf-loc>
          <conf-date>28 September&#x2013;1 October 1988</conf-date>
          <comment>Paper 601</comment>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M668">
        <label>7.</label>
        <citation citation-type="confproc">
          <person-group person-group-type="author">
            <name>
              <surname>Jungheim</surname>
              <given-names>L.N.</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Ternansky</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Stepherd</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Neel</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Draheim</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Pike</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C.Y.E.</given-names>
            </name>
          </person-group>
          <source>Abstracts of 28th Interscience Conference on Antimicrobial Agents and Chemotherapy</source>
          <conf-loc>Los Angels, CA, USA</conf-loc>
          <conf-date>23&#x2013;26 October 1988</conf-date>
          <comment>paper 240</comment>
        </citation>
      </ref>
      <ref id="B8-molbank-2010-M668">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ternansky</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Draheim</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>[3.3.0] Pyrazolidinones: An efficient synthesis of a new class of synthetic antibacterial agents</article-title>
          <source>Tetrahedron Lett.</source>
          <year>1990</year>
          <volume>31</volume>
          <fpage>2805</fpage>
          <lpage>2808</lpage>
          <pub-id pub-id-type="doi">10.1016/0040-4039(90)80153-D</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2010-M668">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangwan</surname>
              <given-names>N.K.</given-names>
            </name>
            <name>
              <surname>Dhindsa</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>O.P.</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <source>Chim. Acta Turc.</source>
          <year>1983</year>
          <volume>11</volume>
          <fpage>65</fpage>
          <lpage>72</lpage>
        </citation>
      </ref>
      <ref id="B10-molbank-2010-M668">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Safak</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tayhan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sarac</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some 1-Acetyl-3,5-diaryl-2-pyrazoline derivatives and their antimicrobial activities</article-title>
          <source>J. Indian Chem. Soc.</source>
          <year>1990</year>
          <volume>67</volume>
          <fpage>571</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="doi">10.1002/chin.199142178</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2010-M668">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nauduri</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>G.B.</given-names>
            </name>
          </person-group>
          <article-title>Antibacterials and Antimycotics: Part 1: Synthesis and Activity of 2-Pyrazoline Derivatives</article-title>
          <source>Chem. Pharm. Bull. (Tokyo)</source>
          <year>1998</year>
          <volume>46</volume>
          <fpage>1254</fpage>
          <lpage>1260</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.46.1254</pub-id>
          <pub-id pub-id-type="pmid">9734312</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2010-M668">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grant</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mishriky</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Asaad</surname>
              <given-names>F.M.</given-names>
            </name>
            <name>
              <surname>Fawzy</surname>
              <given-names>N.G.</given-names>
            </name>
          </person-group>
          <article-title>Pyridines and pyrazolines from salicylic acid derivatives with propenone residue and their antimicrobial properties</article-title>
          <source>Pharmazie</source>
          <year>1998</year>
          <volume>53</volume>
          <fpage>543</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="doi">10.1002/chin.199847057</pub-id>
          <pub-id pub-id-type="pmid">9741063</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2010-M668">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turan-Zitouni</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>&#xD6;zdemir</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>G&#xFC;ven</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some 1-[(N,N-disubstituted thiocarbamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and investigation of their antibacterial antifungal activities</article-title>
          <source>Arch. Pharm. Pharm. Med. Chem.</source>
          <year>2005</year>
          <volume>338</volume>
          <fpage>96</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="doi">10.1002/ardp.200400935</pub-id>
          <pub-id pub-id-type="pmid">15765490</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2010-M668">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turan-Zitouni</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>&#xD6;zdemir</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kaplanc&#x131;kli</surname>
              <given-names>Z.A.</given-names>
            </name>
            <name>
              <surname>Chevallet</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Tunali</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimicrobial activities of some 1-[ (N,N-disubstituted thiocarbamoylthio)acetyl]-3,5,diaryl-2- pyrazolines</article-title>
          <source>Phosphorus Sulfur Silicon Relat. Elem.</source>
          <year>2005</year>
          <volume>180</volume>
          <fpage>2717</fpage>
          <lpage>2724</lpage>
          <pub-id pub-id-type="doi">10.1080/104265090930452</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2010-M668">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nasar</surname>
              <given-names>M.N.A.</given-names>
            </name>
            <name>
              <surname>Said</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Novel 3,3a,4,5,6,7- Hexahydroindazole and arylthiazolyl pyrazoline derivatives of anti- inflammatory agents</article-title>
          <source>Arch. Pharm. Pharm. Med. Chem.</source>
          <year>2003</year>
          <volume>336</volume>
          <fpage>551</fpage>
          <lpage>559</lpage>
          <pub-id pub-id-type="doi">10.1002/ardp.200300796</pub-id>
          <pub-id pub-id-type="pmid">14677148</pub-id>
        </citation>
      </ref>
      <ref id="B16-molbank-2010-M668">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turan-Zitouni</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Chevallet</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kili&#xE7;</surname>
              <given-names>F.S.</given-names>
            </name>
            <name>
              <surname>Erol</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some thiazolyl- pyrazoline derivatives and preliminary investigation of their hypotensive activity</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>635</fpage>
          <lpage>641</lpage>
          <pub-id pub-id-type="doi">10.1016/S0223-5234(00)00152-5</pub-id>
        </citation>
      </ref>
      <ref id="B17-molbank-2010-M668">
        <label>17.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>R.R.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <source>Heterocyclic Chemistry Five- membered Heterocycles</source>
          <publisher-name>Springer- Verlag</publisher-name>
          <publisher-loc>Berlin, Heidelberg, New York</publisher-loc>
          <year>1999</year>
          <volume>Volume 2</volume>
		  <fpage>416</fpage>
        </citation>
      </ref>
      <ref id="B18-molbank-2010-M668">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Onoe</surname>
              <given-names>H.</given-names>
            </name>
			<collab>Takahashi, Jpn. Kokai</collab>
          </person-group>
          <article-title>Tokyo Koho JP 03 87,841</article-title>
		  <source>Chem. Abstr.</source>
          <year>1994</year>
          <volume>121</volume>
          <fpage>205336</fpage>
        </citation>
      </ref>
      <ref id="B19-molbank-2010-M668">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fhamy</surname>
              <given-names>H.T.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimicrobial screening of some novel thiazoles, dithiazoles and thiazolylpyridines</article-title>
          <source>Pharmazie</source>
          <year>1997</year>
          <volume>52</volume>
          <fpage>750</fpage>
          <lpage>753</lpage>
        </citation>
      </ref>
      <ref id="B20-molbank-2010-M668">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pandeya</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Sriram</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Nath</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Declercq</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, antibacterial, antifungal and anti- HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4,(4&#x2019;- Chlorophenyl)thiazol-2-yl]thiosemicarbazide</article-title>
          <source>Eur. J. Pharm. Sci.</source>
          <year>1999</year>
          <volume>9</volume>
          <fpage>25</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1016/S0928-0987(99)00038-X</pub-id>
        </citation>
      </ref>
      <ref id="B21-molbank-2010-M668">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ate&#x15F;</surname>
              <given-names>&#xD6;.</given-names>
            </name>
            <name>
              <surname>Altintas</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>&#xD6;t&#xFC;k</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimicrobial activity of 4-Carbethoxymethyl-2- [(&#x3B1;-haloacyl)amino]thiazoles and 5-non-substituted/substituted 2-[(4-Carbethoxymethylthiazol-2- yl)imino]-4-thiazolidinones</article-title>
          <source>Arzneimittelforschung</source>
          <year>2000</year>
          <volume>50</volume>
          <fpage>569</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="pmid">10918953</pub-id>
        </citation>
      </ref>
      <ref id="B22-molbank-2010-M668">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lakhan</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>B.P.</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>B.N.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimicrobial activity of 1-aryl-2-amino-3-(4-arylthiazol-2-yl)/(benzothiazol-2-yl)guanidines</article-title>
          <source>Farmaco</source>
          <year>2000</year>
          <volume>55</volume>
          <fpage>331</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-827X(00)00032-X</pub-id>
        </citation>
      </ref>
      <ref id="B23-molbank-2010-M668">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplancikli</surname>
              <given-names>Z.A.</given-names>
            </name>
            <name>
              <surname>Turan-Zitouni</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Revial</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>G&#xFC;ven</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and study of antibacterial and antifungal activities of novel 2-[[(benzoxazole/benzimidazole-2-yl)sulfanyl]acetylamino] thiazoles</article-title>
          <source>Arch. Pharm. Res.</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>1081</fpage>
          <lpage>1085</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02975108</pub-id>
          <pub-id pub-id-type="pmid">15595406</pub-id>
        </citation>
      </ref>
      <ref id="B24-molbank-2010-M668">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turan-Zitouni</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Demirayak</surname>
              <given-names>&#x15E;.</given-names>
            </name>
            <name>
              <surname>&#xD6;zdemir</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kaplanc&#x131;kl&#x131;</surname>
              <given-names>Z.A.</given-names>
            </name>
            <name>
              <surname>Y&#x131;ld&#x131;z</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of some 2-[(benzazole-2-yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2004</year>
          <volume>39</volume>
          <fpage>267</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2003.11.001</pub-id>
          <pub-id pub-id-type="pmid">15051175</pub-id>
        </citation>
      </ref>
      <ref id="B25-molbank-2010-M668">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashtekar</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Khadse</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Shirodkar</surname>
              <given-names>M.V.A.</given-names>
            </name>
          </person-group>
          <article-title>A rapid method for the evaluation of new antituberculosis agents</article-title>
          <source>Chemotherapy</source>
          <year>1987</year>
          <volume>33</volume>
          <fpage>22</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1159/000238472</pub-id>
          <pub-id pub-id-type="pmid">3103991</pub-id>
        </citation>
      </ref>
      <ref id="B26-molbank-2010-M668">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maass</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Immendoerfer</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Koenig</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Leser</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Goody</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Pfatt</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Viral resistance to the thiazolo- iso- indolinones, a new class of nonnucleoside inhibitors of HIV virus type 1 reverse transcriptase</article-title>
          <source>Antimicrob. Agents Chemother.</source>
          <year>1993</year>
          <volume>37</volume>
          <fpage>2612</fpage>
          <lpage>2617</lpage>
          <pub-id pub-id-type="doi">10.1128/AAC.37.12.2612</pub-id>
          <pub-id pub-id-type="pmid">7509144</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
